SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-14 |
| Reported value | $4,941,404,255 |
| Positions | 117 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| Scholar Rock Holding Corp | SRRK | COM | $526,625,715 | 9,575,013 |
| Kymera Therapeutics Inc | KYMR | COM | $336,651,626 | 2,935,830 |
| Erasca Inc | ERAS | COM | $208,807,348 | 11,397,781 |
| Veradermics Inc | MANE | COMMON STOCK | $203,511,680 | 1,655,374 |
| Tango Therapeutics Inc | TNGX | COM | $193,166,919 | 6,179,364 |
| Revolution Medicines Inc | RVMD | COM | $168,552,000 | 900,000 |
| Bicara Therapeutics Inc | BCAX | COM | $166,352,179 | 5,602,970 |
| Arrowhead Pharmaceuticals Inc | ARWR | COM | $139,828,449 | 1,715,476 |
| BeOne Medicines AG | ONC | SPONSORED ADS | $132,511,050 | 465,000 |
| Edgewise Therapeutics Inc | EWTX | COM | $129,391,476 | 3,184,629 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.